Daily Archives: July 13, 2015

Ban urges South Sudan leaders to ‘give up war’ and forge a political agreement

13 July 2015 – Just days after marking the somber fourth anniversary of South Sudan’s independence, United Nations Secretary-General Ban Ki-moon today urged the leaders of the country to end hostilities and to move beyond their “partial interests” and show courage and leadership.

“Today, I repeat my call to President Kiir and former Vice-President Dr. Riek Machar to give up war – for the sake of the people and future of South Sudan. I urge them to compromise, forge a political deal and make true on their promises to protect their people,” declared Secretary-General Ban Ki-moon from Addis-Ababa, where he is attending the Third International Conference on Financing for Development.

Speaking to the press after a “productive” meeting with Hailemariam Desalegn, Prime Minister of Ethiopia, and Nkosazana Dlamini Zuma, Chairperson of the African Union Commission, he said the United Nations is offering full support to Intergovernmental Authority on Development Partners Forum (IGAD), “so that collectively we show the parties a single way forward.”

“We are in agreement. The conflict in South Sudan must stop,” Mr. Ban stated.

Recalling vividly the high hopes invested in this new nation at its birth four years ago, he said he was “heartbroken” for the people of South Sudan whose aspirations for a peaceful and prosperous future have been “shattered so unnecessarily, so tragically.”

The humanitarian situation in the country is “appalling”, with over 1.6 million displaced people and over 600,000 refugees in the neighboring countries, and close to 4.6 million facing severe food insecurity. Parties must respect international humanitarian law and enable unfettered access to those in need of assistance, stressed the Secretary-General.

Deeply disturbed by the level of violence and the unspeakable atrocities committed against civilians, he reminded all parties to the conflict that those responsible for serious human rights violations will be held accountable.

“True leadership means making compromises. It means stopping the fighting, stopping the killing and raping, stopping the destruction of the country.”

Convinced that peace in South Sudan also requires support from its neighbors, the UN top official also urged Uganda President Yoweri Museveni and Sudan President Omar Al-Bashir to use their influence on the parties to help end this conflict.

The UN Mission in South Sudan (UNMISS) is now accommodating more than 150,000 internally displaced persons, which is a figure that it was never deal with in the first place. Despite this difficult position, UNMISS is doing its best to provide life-saving support to them, added the Secretary-General, expecting South Sudan authorities to “fully” cooperate and provide support.

EIB supports Cavidi’s development of HIV viral load monitoring device

Cavidi InnovFin IDFF

No download formats are defined.

Cavidi InnovFin IDFF

The project consists of the development, production and market launch of an automated version of a HIV viral load measuring device which would allow for a higher throughput, ability to detect all HIV types and perform early infant detection of HIV. The new device will lower the manual steps necessary for running the tests from 5 to 3 thus also reducing the training necessary for staff running the tests.

© Cavidi

Rights Free

The European Investment Bank (EIB) has provided a EUR 10 million long-term loan to Swedish biotech company Cavidi AB for developing a next generation automated testing device for HIV viral load. This is the first transaction under InnovFin Infectious Diseases, an innovative high risk-taking financial instrument recently established within the new generation of financial products for innovative and growth companies – InnovFin.

Cavidi’s novel technology for HIV monitoring is proven to work in simple and less sophisticated laboratories, such as a non-cleanroom environment. These are common in low and middle-income countries, which are often hit worst by the HIV pandemic. The new testing device represents a breakthrough as the correct measurement of the actual viral load in HIV patients can contribute enormously to the efforts to reduce the growing AIDS epidemic – maintaining a low viral load reduces the chances of transmission of the virus.

The company expects to launch this next generation HIV viral load monitor during 2016 and to quickly gain a significant share of the market for HIV diagnostics in near point of care centres such as district hospital laboratories in low and middle-income countries.

This first EIB operation under InnovFin Infectious Diseases is supported by the new generation of financial instruments for innovative and growth companies “InnovFin – EU Finance for Innovators”, with the financial backing of the European Union under Horizon 2020. The aim of InnovFin Infectious Diseases is to allow the EIB to fund high-risk projects in the area of infectious diseases, where the risk is linked to the successful development of innovative vaccines, drugs or medical devices, and to their future commercialisation.

Jonathan Taylor, EIB Vice-President with responsibility for lending in Sweden, stated: “We are pleased to be partnering with Cavidi in this breakthrough operation as it will enable the EU bank to support future technologies whose concrete applications will effectively tackle the HIV pandemic. With this first InnovFin Infectious Diseases loan we confirm our commitment to providing easier access to finance, especially for higher-risk projects, in the medical sector. This is crucial to bridging the gap from pure research and development to commercially viable enterprises in Europe. Projects like this strengthen the competitiveness and boost the innovative capacity of European health-related industries and businesses, so enhancing Europe’s position as a major technology supplier and supporting skilled employment opportunities.”

John Reisky de Dubnic, CEO of Cavidi added: “The EIB’s new financing vehicles will play a key role in developing innovative companies and new commercial successes. These new financing sources are crucial as they are some of the few available for companies moving from an R&D success to a commercial product. We have a proven and effective technology that can benefit millions of people in high-burden countries. This support from the EIB will help us realise our technology faster and increase access to viral load monitoring for those living with HIV who need it most.”

Carlos Moedas, European Commissioner for Research, Science and Innovation, said: “This first loan under InnovFin Infectious Diseases will not only help speed up the development of an innovative device for monitoring HIV treatment for the benefit of patients, but will also support the growth of an innovative family-owned European business. This is one of many examples of how Horizon 2020, the EU funding programme for research and innovation, addresses major societal challenges, while stimulating European competitiveness and growth.”

Effective HIV monitoring reduces the cost of medication and the risk that a person living with HIV will infect others. It therefore helps manage the disease effectively and limits its spread and the future suffering and costs to society that this will cause.

Background information

About EIB

The European Investment Bank (EIB) is the long-term lending institution of the European Union and is owned by the EU Member States. It makes long-term finance available for sound investment in order to contribute towards EU policy goals. In 2014, EIB financing in Sweden amounted to EUR 1.41 billion, with the main focus on projects promoting sustainable transport, energy efficiency and urban development (for more details click here).

About Cavidi

Cavidi is Sweden’s leading supplier of HIV viral load monitoring equipment. Its products enable efficient management of anti-HIV drugs so that people with HIV can enjoy a normal lifespan. Cavidi’s viral load diagnostics reduce the cost of treatment and the spread of HIV. Cavidi is a Swedish biotech company and uses methods and research from leading virologists from Uppsala University. Cavidi has offices in Sweden, South Africa, India and the USA.

About InnovFin financial products

Under Horizon 2020, the new EU research programme for 2014-20, the European Commission and the European Investment Bank Group (EIB and EIF) have launched a new generation of financial instruments and advisory services to help innovative firms access finance more easily. Over the next seven years, “InnovFin – EU Finance for Innovators” will offer a range of tailored products which will make available more than EUR 24bn of financing support for research and innovation (R&I) by small, medium-sized and large companies and the promoters of research infrastructures. This finance is expected to support up to EUR 48bn of final R&I investments.

InnovFin builds on the success of the Risk-Sharing Finance Facility developed under the seventh EU framework programme for research and technological development (FP7), which financed 114 R&I projects to the tune of EUR 11.3bn and in addition provided loan guarantees worth over EUR 1.4bn.

Backed by funds set aside under Horizon 2020 and by the EIB Group, InnovFin financial products support R&I activities, which by their nature are riskier and harder to assess than traditional investments and therefore often face difficulties in accessing finance. All are demand-driven instruments, with no prior allocations between sectors, countries or regions. Firms and other entities located in EU Member States and Horizon 2020 Associated Countries will be eligible as final beneficiaries.

InnovFin Infectious Diseases is a new risk-sharing facility designed to stimulate investment in R&D activities targeting the development of innovative vaccines, drugs, medical and diagnostic devices or novel research infrastructures for infectious diseases. With this facility, the EIB will target project developers in the field of infectious diseases that have successfully completed the pre-clinical stage and preferably early stage clinical development and now require clinical validation or are ready for later stage clinical trials. EU funding will enable the EIB to offer a range of higher risk financial products ranging from standard debt instruments (i.e. senior, subordinated, and mezzanine) to risk-sharing instruments with forgiveness options in the case of failure of the projects supported. To mitigate the inherent risks of the facility and ensure the most beneficial allocation of funds, targeted projects should exhibit a proven public health impact and market potential and enjoy the commitment of promoters to substantially co-fund the project.

Financing for Development Conference Kicks Off in Addis

The biggest development conference in a decade kicks off in Ethiopia today. Heads of state, ministers of finance and dignitaries from the public and private sector are coming together for a week of meetings focused on funding sustainable development. “The announcements of new public commitments have already begun. On Friday the International Monetary Fund, the World Bank, and five big regional development banks pledged $400bn in lending over the next three years. The World Bank and others are also unveiling facilities for women’s and children’s health and to allow governments in the developing world to take advantage of the bank’s triple A credit rating and issue new bonds at lower interest rates. There will also be an emphasis during the conference on helping developing economies mobilise their own public resources and improve how they collect taxes and other tasks.” (FT http://on.ft.com/1HpiDmi)

Take a Deeper Dive…If you have 15 minutes and want a good curtain raiser on this conference, including the big points of convergence and contention between the major players and some of the expected official and unofficial outcomes, listen to Mark’s podcast episode with Minh Thu Pham of the United Nations Foundation. (Global Dispatches Podcast http://bit.ly/1HpiiQJ)

Happy Birthday, Malala… Malala Yousafzai, the youngest winner of the Nobel Peace Prize, celebrated her 18th birthday in Lebanon on Sunday by opening a school for Syrian refugee girls, repeating her call for world leaders to invest in “books not bullets” (SMH http://bit.ly/1HpiRKi)

So much for the Ceasefire...Fighting near the southern Yemeni city of Aden killed 35 people on Sunday, the exiled government said, in breach of a temporary humanitarian truce brokered by the United Nations. (Reuters http://reut.rs/1Hpj3Jz)

Quote of the Day: “Putting bread on the table, putting a roof over the heads of one’s children, giving them health and an education, these are essential for human dignity,” he said,” Pope Francis (yes, again) while in Asuncion. http://yhoo.it/1fAKrv5

Africa

Suspected Boko Haram militants launched an attack on the prison in the southern Niger town of Diffa late on Saturday, military sources said, in an apparent bid to free fellow members of the Nigerian Islamist group held there. (Reuters http://bit.ly/1DaNYVW)

Burundi’s army has captured scores of gunmen and killed others in two days of clashes in the north, a regional governor said on Sunday, the latest flare-up of violence in a nation that emerged from civil war in 2005. (Reuters http://bit.ly/1DaO5kk)

Chadian police on Sunday warned that anyone found wearing the Muslim full-face veil would be arrested, after a Boko Haram suicide bombing in the capital left 15 dead. (AFP http://yhoo.it/1Jd1EBL)

A U.N. diplomat based in South Sudan’s northern Unity state will be expelled from the state in a retaliatory move following the publication of a human rights report last month that accused government forces of committing widespread attacks on civilians there, a South Sudanese official said Sunday. (AP http://yhoo.it/1Jd1H0v)

MENA

Major issues remain unresolved in the Iran nuclear talks, a senior U.S. official said on Sunday in a comment that appeared designed to play down speculation that an agreement was imminent. (Reuters http://yhoo.it/1HzdZPG)

Car bombs and suicide attacks targeting mainly Shiite Muslim districts of Baghdad have killed 35 people, one of the heaviest recent tolls in the Iraqi capital which has faced a wave of bombings by Islamic State militants. (ABC-Australia http://ab.co/1HpiZJL)

Israel on Sunday released a Palestinian prisoner who staged a 56-day hunger strike that brought him near death in a protest against a controversial procedure allowing indefinite detention without charge. (AFP http://yhoo.it/1HzdUeL)

An Israeli human rights group released a video Sunday that purports to show a high-ranking Israeli officer fatally shooting a fleeing Palestinian teenager who had thrown a rock at his vehicle, smashing its windshield. (AP http://yhoo.it/1Jd1IBC)

Asia

Several hundred workers in Myanmar rallied Sunday for a higher minimum wage despite a warning by factory owners that the demand might put them out of business. (AP http://yhoo.it/1Hze0my)

In a nation where religion and ethnicity are incendiary issues, a selfie campaign by Myanmar students promoting cross-cultural friendships has become a rare counterpoint to bilious anti-Muslim rhetoric from hardline Buddhist monks. (AFP http://yhoo.it/1HzdYuV)

Many people living in this coastal village in Vanuatu believe the March cyclone that sent waves surging through their homes was the latest and most dramatic sign of climate change. They are now considering rebuilding their entire community on higher ground. (AP http://yhoo.it/1Hze1qL)

A judge on China’s highest court has come under investigation for corruption, becoming one of the most senior judicial officials to be swept up by the country’s anti-graft dragnet. (Reuters http://yhoo.it/1fAKy9S)

Police who seized Asia’s largest known shipment of liquid cocaine at a Bangladeshi port late last month say it was headed for India, the latest sign that drug cartels are increasingly plying their trade in South Asia. (Reuters http://yhoo.it/1fAKyH4)

China says 109 ethnic Uighurs who were deported from Thailand last week were heading to Turkey, Syria or Iraq to join Islamic militants. (VOA http://bit.ly/1HVSIpI)

A suicide car bomb killed 25 people and wounded 10 in southeastern Afghanistan close to a U.S. base on Sunday, police said. (Reuters http://reut.rs/1HpiYFz)

The Americas

Pope Francis, wrapping up his three-country tour of South America, on Sunday urged people living in a flood-prone shantytown in Paraguay to stay united in their struggle for better living and working conditions. (Reuters http://yhoo.it/1JZCRqw)

Mexico mounted an all-out manhunt Sunday for its most powerful drug lord, Joaquin “El Chapo” Guzman, who escaped from a maximum security prison through a 1 mile tunnel from a small opening in the shower area of his cell, according to the country’s top security official. (AP http://yhoo.it/1HzdXHo)

Pope Francis is balancing out his apology for the crimes the Catholic Church committed against indigenous during the colonial-era conquest of the Americas with high praise for the Jesuit missions in Paraguay that brought Christianity and European-style education and economic organization to the natives. (AP http://yhoo.it/1fAKuHd)

Colombia pledged on Sunday to de-escalate military action against leftist guerrillas if the rebels uphold their unilateral ceasefire, providing a breakthrough in peace talks that had been threatened by an escalation of battlefield violence. (Reuters http://yhoo.it/1Jd1HgY)

…and the rest

Opinion/Blogs

To Resurrect A Vanishing Language, Try YouTube and Indiegogo (Goats and Soda http://n.pr/1O4qEQa

Will the Addis financing summit make a difference? (ODI http://bit.ly/1M4TIbQ)

The case for well-planned infrastructure mega-projects (An Africanist Perspective http://bit.ly/1O4qTux)

50,000 images of Africa that are not from Africa (WhyDev http://bit.ly/1O4qTum)

Lessons from Make Poverty History (Global Dashboard http://bit.ly/1O4qUyu)

Why Australian aid cuts are harmful for Afghanistan (Devpolicy http://bit.ly/1O4qTdS)

Craig Murray: IMF and USA set to ruin Ghana (Development Truths http://bit.ly/1O4qSXm)

Discussion

comments…

30 innovations that could transform global health: Introducing the Innovation Countdown 2030 report

– PATH leads global initiative to crowdsource and assess innovations with the potential to save millions of lives by 2030

ADDIS ABABA, Ethiopia, July 13, 2015 /PRNewswire/ — The PATH-led Innovation Countdown 2030 initiative (IC2030) today launched its inaugural report, Reimagining Global Health, at the Third International Conference on Financing for Development. The report features 30 innovations selected by international experts for their lifesaving potential and can be downloaded at www.ic2030.org.

2015 marks a seminal moment in global health as world leaders coalesce around new global goals that will determine the international development agenda and health investments over the next 15 years. Innovative technologies and approaches that make health care more affordable, more effective, and easier to access are key to reaching the new health goals by 2030.

Reimagining Global Health is the result of a yearlong process to identify, evaluate, and showcase some of those high-potential health technologies and ideas, with the goal of catalyzing investment and support.

Two innovations found to have exceptional potential are a simple, low-cost antiseptic to prevent newborn infections and new technologies for small-scale water treatment at the community level. These two innovations alone, with expanded use, could save the lives of 2.5 million newborns and children by 2030.

Tapping innovation around the world

PATH sought ideas from experts, innovators, and technology developers worldwide, crowdsourcing solutions with great promise to accelerate progress toward reaching the 2030 health targets.

People in nearly 50 countries nominated more than 500 innovations for consideration. Dozens of independent health experts then assessed and ranked them, selecting the 30 innovations featured in the report.

“Innovation is the essential ingredient in empowering communities with solutions they can use to transform their own health,” said Steve Davis, PATH president and CEO. “To achieve the 2030 health targets, we must focus our brightest minds, collective resources, and shared aspirations on accelerating innovations with the most potential for impact.”

“World leaders are coming together in 2015 around new global goals that can ensure good health and equal opportunity for all. By prioritizing and coordinating investments in innovations that can deliver the greatest health value for money, we can create financially sustainable solutions that reach the millions of people who have yet to share in the gains of our progress,” said Mr. Borge Brende, Minister of Foreign Affairs, Norway.

The initiative is supported by the Norwegian Agency for Development Cooperation, the Bill & Melinda Gates Foundation, and the US Agency for International Development.

Innovations to tackle the world’s most urgent health issues

The 30 selected innovations cover four health areas:

  • Maternal, newborn, and child health, an area featuring innovations such as a uterine balloon tamponade to manage excessive bleeding after childbirth, the leading cause of maternal death; portable devices that measure oxygen levels in the blood to improve detection of pneumonia, the top killer of young children; and new treatments for severe diarrhea, another major cause of child deaths.
  • Infectious diseases, where key innovations include malaria vaccine candidates, long-acting injectable drugs to treat HIV infection, and a novel multidrug treatment regimen to shorten the treatment for tuberculosis.
  • Reproductive health, where new injectable contraceptives and expanded access to long-acting, reversible contraceptives such as intrauterine devices may have great impact.
  • Noncommunicable diseases, where potentially transformative innovations include the use of a low-cost polypill to prevent cardiovascular disease and the use of mobile devices for chronic disease prevention and management.

“IC2030 identifies health solutions that have the potential to make a catalytic impact in global health over the next 15 years,” said Chris Elias, president of Global Development, Bill & Melinda Gates Foundation. “By finding and amplifying promising ideas and strengthening the capacity of low-resource countries to develop, introduce, and share innovation, we can accelerate progress so that every person has an equal chance for a healthy and productive life.”

Leading experts on health innovation

The report also includes commentaries by leading health, business, and technology experts on the essential role of innovation in driving health impact.

Amie Batson, PATH’s chief strategy officer, highlights four key strategies to accelerate health innovation:  sourcing health solutions globally, identifying innovations that deliver the greatest value for the money, developing new financing mechanisms, and coordinating investments.

Other authors featured in the report include Mark Dybul of the Global Fund to Fight AIDS, Tuberculosis and Malaria; Flavia Bustreo of the World Health Organization; Christopher Murray of the Institute for Health Metrics and Evaluation; Navi Radjou, author of Frugal Innovation; and Lawrence Summers, former US Treasury Secretary.

Measuring health impact

A key feature of IC2030 is the health and cost impact modeling process PATH developed with its partner, Applied Strategies, to measure lives saved, cases of disease averted, and costs for health innovations.

The data provide new insights into how to prioritize global health investments for the greatest impact. For example, the modeling identified two innovations with especially high potential for saving lives:

  • Community-level water treatment tools to prevent diarrheal disease would save an estimated 1.5 million children by 2030, with a predicted savings of $1.2 billion by reducing diarrhea incidence and treatment costs.
  • Scaled-up use of a low-cost antiseptic called chlorhexidine to prevent newborn infections would save an estimated 1 million newborns by 2030 at an estimated cost of $81 million.

“As countries begin to experience an economic transition of health, many will increasingly be able to afford basic services to bring an end to preventable child and maternal deaths – yet many others will not,” said Dr. Ariel Pablos-Mendez, Child and Maternal Survival Coordinator and Assistant Administrator for Global Health of the U.S. Agency for International Development. ”Innovations in technology and management will be essential to reach our ambitious targets by 2030.”

Next steps

PATH aims to continue IC2030, building on this platform to give greater voice to innovators from around the world, to engage experts from across sectors and disciplines, and to raise awareness and visibility of transformative innovations to influence decision-making and investment.

To learn more about IC2030 and to download the report, please visit: www.ic2030.org.

PATH

PATH is the leader in global health innovation. An international nonprofit organization, PATH saves lives and improves health, especially among women and children. PATH accelerates innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—that harness our entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, PATH takes innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. With these key partners, PATH delivers measurable results that disrupt the cycle of poor health. Learn more at www.path.org.

Norwegian Agency for Development Cooperation

The Norwegian Agency for Development Cooperation (Norad) was established in 1962 and is part of the Norwegian Ministry of Foreign Affairs. Its main objectives are to make Norwegian development aid as effective as possible, to ensure that funds are spent in the best possible way, and to report on what is and is not successful. Norad provides expert advice about development and aid to the Foreign Service and works together with a range of other players in development assistance. In 2012, Norad managed 12 percent of the NOK28 billion that Norway provided in development assistance. Learn more:http://www.norad.no/en/front-page

Bill & Melinda Gates Foundation

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Sue Desmond-Hellmann and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.

US Agency for International Development

The U.S. Agency for International Development is leading the U.S. Government’s efforts to end extreme poverty and promote resilient, democratic societies. USAID has been the leading donor in international family planning for more than 50 years—both in terms of financial resources, advancing the development of safe, effective, and acceptable contraceptives and multipurpose prevention technologies designed specifically for provision and use in low-resource settings, and supporting program innovation, implementation, and evaluation.

30 innovations susceptibles de transformer la santé à travers le monde : présentation du rapport Innovation Countdown 2030

– PATH à la tête d’une initiative mondiale d’externalisation ouverte et d’évaluation d’innovations susceptibles de sauver plusieurs millions de vies d’ici 2030

ADDIS-ABEBA, Éthiopie, le 13 juillet 2015 /PRNewswire/ — L’initiative Innovation Countdown 2030 (IC2030) dirigée par PATH a présenté aujourd’hui son rapport inaugural, intitulé Reimagining Global Health (Ré-imaginer la santé à travers le monde), lors de la troisième Conférence internationale sur le financement et le développement. Ce rapport fait intervenir 30 innovations, sélectionnées par des experts internationaux en tant qu’outils susceptibles de sauver des vies. Il est disponible au téléchargement sur www.ic2030.org.

L’année 2015 constitue un moment phare pour la santé aux quatre coins du globe, au cours de laquelle les dirigeants mondiaux s’uniront autour de nouveaux objectifs internationaux voués à déterminer l’agenda du développement international et des investissements dans la santé pour les 15 prochaines années. Les technologies et approches innovantes, susceptibles de rendre les soins de santé plus abordables, plus efficaces et plus faciles d’accès, constituent la clé d’une avancée en direction de nouveaux objectifs de santé d’ici 2030.

Le rapport Reimagining Global Health est le fruit d’un processus d’un an consistant à identifier, à évaluer et à présenter certaines de ces technologies et idées à fort potentiel en matière de santé, avec pour objectif de catalyser l’investissement et le soutien.

Il est apparu que deux innovations présentant un potentiel exceptionnel résidaient dans un antiseptique simple et peu coûteux, permettant de prévenir les infections chez les nouveau-nés, ainsi que dans de nouvelles technologies de traitement de l’eau à petite échelle, au niveau des communautés. À elles seules, ces deux innovations pourraient permettre, à condition d’une utilisation généralisée, de sauver 2,5 millions de nouveau-nés et enfants d’ici 2030.

Tirer parti de l’innovation à travers le monde

PATH a fait appel aux idées des experts, innovateurs et développeurs technologiques du monde entier, en externalisant de manière ouverte un certain nombre de solutions constitutives d’une formidable promesse d’accélération des progrès en direction de l’accomplissement des objectifs de santé pour 2030.

Des personnes issues de près de 50 pays ont nominé plus de 500 innovations afin que celles-ci soient prises en considération. Plusieurs dizaines d’experts sanitaires indépendants les ont ensuite évaluées et notées, sélectionnant ensuite les 30 innovations apparaissant dans le rapport.

« L’innovation est un ingrédient essentiel à l’apport d’un soutien aux communautés via des solutions qu’elles peuvent utiliser afin de transformer leur propre santé, » a déclaré Steve Davis, président et PDG de PATH. « Afin d’atteindre les objectifs de santé 2030, nous devons nous focaliser sur les esprits les plus brillants, sur des ressources collectives, ainsi que sur des aspirations partagées autour de l’accélération des innovations présentant le plus fort potentiel d’impact. »

« Les leaders du monde entier se réunissent en 2015 autour de nouveaux objectifs internationaux capables de garantir une bonne santé et des opportunités égales pour tous. En hiérarchisant et coordonnant les investissements en innovations susceptibles de présenter la meilleure rentabilité en termes de santé, nous sommes en mesure de créer des solutions financièrement durables, destinées au millions de personnes qui ne partagent pas encore les gains associés à nos progrès, » a déclaré M. Borge Brende, ministre norvégien des Affaires étrangères.

Cette initiative est soutenue par l’Agence norvégienne de coopération pour le développement, la Fondation Bill & Melinda Gates, ainsi que l’Agence américaine pour le développement international.

Produire des innovations permettant de faire face aux défis sanitaires les plus urgents de la planète

Les 30 innovations sélectionnées couvrent quatre domaines sanitaires :

  • La santé des mères, des nouveau-nés et des enfants, un domaine faisant intervenir des innovations telles que le tamponnement intra-utérin par ballonnet, qui permet de gérer les saignements excessifs après l’accouchement, principale cause de mortalité en couche ; les dispositifs portables permettant de mesurer les niveaux d’oxygène dans le sang, afin d’améliorer la détection d’une pneumonie, première cause de décès des jeunes enfants ; ainsi que de nouveaux traitements des diarrhées sévères, autre cause majeure de décès infantiles.
  • Les maladies infectieuses, domaine dans lequel les innovations clés résident dans des vaccins candidats contre le paludisme, des médicaments injectables et à action prolongée permettant de traiter l’infection au VIH, ainsi qu’un nouveau régime thérapeutique multi-médicamenteux permettant de raccourcir la durée du traitement contre la tuberculose.
  • La santé reproductive, domaine dans lequel un formidable impact pourrait être généré par de nouveaux contraceptifs injectables, ainsi que par le développement de l’accès à des contraceptifs réversibles à action prolongée, tels que les dispositifs intra-utérins.
  • Les maladies non transmissibles, domaine dans lequel les innovations potentiellement transformatrices résident notamment dans l’utilisation d’une polypilule à bas coût permettant de prévenir les maladies cardiovasculaires, ainsi que dans l’utilisation de dispositifs mobiles de prévention et de gestion des maladies chroniques.

« L’IC2030 identifie des solutions de santé susceptibles d’apporter un effet catalyseur sur la santé mondiale au cours des 15 prochaines années, » a déclaré Chris Elias, président du développement international, Fondation Bill & Melinda Gates. « En identifiant et en amplifiant des idées prometteuses, ainsi qu’en renforçant la capacité des pays pauvres en ressources à développer, introduire et partager des innovations, nous pourrons accélérer les progrès afin que chaque individu ait une chance égale de vivre une existence productive et en bonne santé. »

Point de vue des experts leaders en innovations de santé

Le rapport inclut également les commentaires d’experts leaders dans les domaines de la santé, des affaires, et des technologies, autour du rôle essentiel de l’innovation dans l’émergence d’un impact sur la santé.

Amie Batson, directrice de la stratégie chez PATH, souligne quatre stratégies clés susceptibles d’accélérer l’innovation en matière de santé : externalisation de solutions de santé à travers le monde, identification des innovations les plus prometteuses de rentabilité, développement de nouveaux mécanismes de financement, et coordination des investissements.

Figurent parmi les autres auteurs intervenant dans ce rapport : Mark Dybul, du Fonds mondial de lutte contre le sida, la tuberculose et le paludisme ; Flavia Bustreo, de l’Organisation mondiale de la santé ; Christopher Murray, de l’Institut des mesures et évaluations sur la santé ; Navi Radjou, auteur de l’ouvrage intitulé Frugal Innovation ; et Lawrence Summers, ancien Secrétaire du Trésor américain.

Mesurer l’impact sur la santé

Figure parmi les éléments clés de l’IC2030 le processus de modélisation des impacts en termes de santé et de coûts qu’a développé PATH aux côtés de son partenaire Applied Strategies, afin de mesurer le nombre de vies sauvées, de cas de maladie évités, ainsi que les coûts des innovations de santé.

Ces données fournissent de nouvelles informations sur la manière de hiérarchiser les investissements internationaux du domaine de la santé afin qu’ils génèrent le plus fort impact. Par exemple, la modélisation a permis d’identifier deux innovations présentant un potentiel particulièrement élevé en termes de nombre de vies sauvées :

  • L’outil de traitement des eaux à l’échelle de la communauté destiné à prévenir les maladies diarrhéiques pourrait sauver d’après les estimations environ 1,5 million d’enfants d’ici 2030, tout en économisant près d’1,2 milliard $ grâce à la réduction des épisodes diarrhéiques et des coûts de traitement.
  • L’utilisation à grande échelle d’un antiseptique à bas coût, baptisé chlorhexidine, destiné à prévenir les infections chez les nouveau-nés, permettrait d’après les estimations de sauver 1 million de nouveau-nés d’ici 2030, pour un coût estimé à 81 millions $.

« À l’heure où les États commencent à vivre une transition économique en matière de santé, beaucoup seront de plus en plus capables de s’offrir des services de base afin de mettre un terme aux décès préventibles chez la mère et l’enfant – même si beaucoup d’autres n’en seront pas capables, » a déclaré le Dr Ariel Pablos-Mendez, coordinateur de survie chez la mère et l’enfant et directeur assistant en santé mondiale au sein de l’Agence américaine pour le développement international. « Les innovations dans les domaines de la technologie et de la gestion sont essentielles afin d’atteindre ces objectifs ambitieux d’ici 2030. »

Prochaines étapes

PATH entend poursuivre la démarche IC2030, en bâtissant sur cette plateforme afin de donner davantage de voix aux innovateurs du monde entier, de mobiliser les experts de divers secteurs et disciplines, ainsi que de développer la sensibilisation et la visibilité autour des innovations transformatrices, de sorte d’influer sur la prise de décisions et l’investissement.

Pour en savoir plus sur l’IC2030 et télécharger le rapport, rendez-vous sur : www.ic2030.org.

PATH

PATH est leader des innovations de santé à travers le monde. En tant qu’organisation internationale à but non lucratif, PATH contribue à sauver des vies et à améliorer la santé, notamment parmi les femmes et les enfants. PATH œuvre pour l’accélération de l’innovation au travers de cinq plateformes — vaccins, médicaments, diagnostics, dispositifs et autres innovations liées aux systèmes et services — qui tirent parti de la vision entrepreneuriale de l’organisation, de son expertise en matière de sciences et de santé publique, ainsi que de sa passion autour de l’égalité en matière de santé. En mobilisant ses partenaires du monde entier, PATH donne de l’ampleur à l’innovation, en travaillant principalement aux côtés de pays d’Afrique et d’Asie, afin d’appréhender leurs besoins majeurs en matière de santé. Grâce à ces partenaires clés, PATH produit des résultats mesurables, qui viennent rompre le cycle de situations sanitaires défavorables. En savoir plus sur www.path.org.

Agence norvégienne de coopération pour le développement

L’Agence norvégienne de coopération pour le développement (Norad) a été créée en 1962, et appartient au ministère norvégien des Affaires étrangères. Ses principaux objectifs consistent à rendre aussi efficace que possible l’aide au développement fournie par la Norvège, à veiller à ce que les fonds soient employés de la meilleure manière possible, ainsi qu’à formuler les rapports sur les réussites et les échecs en la matière. La Norad fournit une expertise-conseil au Service extérieur en matière de développement et d’aide, travaillant également auprès de divers autres acteurs de l’aide au développement. En 2012, la Norad a géré 12 pour cent des 28 milliards NOK fournis par la Norvège dans le cadre de l’aide au développement. En savoir plus sur : http://www.norad.no/en/front-page

Fondation Bill & Melinda Gates

Guidée par sa croyance en l’égalité de la valeur de chaque vie, la Fondation Bill & Melinda Gates travaille à aider tout un chacun à mener une vie saine et productive. Dans les pays en voie de développement, la Fondation s’emploie à améliorer la santé des populations, et contribue à leur donner une chance de sortir de la faim et de la misère. Aux États-Unis, la Fondation a pour vocation de faire en sorte que tous les individus — et notamment les plus démunis — puissent avoir accès aux opportunités essentielles pour réussir à l’école comme dans la vie. Le siège de la Fondation se situe à Seattle, dans l’État de Washington, et est dirigée par Sue Desmond-Hellmann, PDG, et William H. Gates Sr., co-président, sous la direction de Bill et Melinda Gates ainsi que de Warren Buffett.

Agence américaine pour le développement international

L’Agence américaine pour le développement international (USAID) gère les efforts du gouvernement américain visant à mettre un terme à l’extrême pauvreté ainsi qu’à promouvoir l’existence de sociétés résilientes et démocratiques. Depuis plus de 50 ans, l’USAID se démarque comme le principal donateur international en matière de planning familial — à la fois en termes de ressources financières, de promotion du développement de contraceptifs sûrs, efficaces et acceptables, ainsi que de technologies de prévention à objectifs multiples, conçues spécifiquement pour être fournies et utilisées dans des environnements à faibles ressources, ainsi qu’en matière de soutien des programmes d’innovation, de mise en œuvre et d’évaluation.